Skip to main content

Joaquin Burgos Cibrian

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca

Joaquin Burgos Cibrian

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca

Projects

Oral Human papillomavirus (HPV) infection and oral HPV-related lesions in HIV-Infected Men who have Sex with Men (MSM): a longitudinal cohort sudy.

IP: Joaquin Burgos Cibrian
Collaborators: -
Funding agency: MERCK SHARP DOHME ESPAÑA SA
Funding: 76235.9
Reference: MSD/MISP/2018/BURGOS
Duration: 01/03/2019 - 28/02/2021

Malalties Infeccioses

IP: Benito Almirante Gragera
Collaborators: Joaquin Burgos Cibrian
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 35200
Reference: 2017SGR1055
Duration: 01/01/2017 - 30/09/2021

Estudio sobre la eficacia y seguridad de la electrocoagulación vs sinecatequinas tópicas vs cidofovir tópico en el tratamiento de la neoplasia intraepitelial anal de alto grado

IP: Joaquin Burgos Cibrian
Collaborators: Adria Curran Fàbregas, Vicenç Falcó Ferrer, Bibiana Planas Ribas
Funding agency: Instituto de Salud Carlos III
Funding: 134915
Reference: PI16/00736
Duration: 01/01/2017 - 30/06/2021

Incorporació Dr. Esteve Ribera a la RETICS en SIDA

IP: -
Collaborators: Adria Curran Fàbregas, Vicenç Falcó Ferrer, Inmaculada Ocaña Rivera, Estrella Caballero Requero, Ariadna Rando Segura, David Perea Pérez, Pere Soler Palacín, María José Buzón Gómez, Paula Suanzes Diez, Jordi Navarro Mercadé, Joaquin Burgos Cibrian, Nerea Sanchez Gaona, Joan Rey Cano, Meritxell Genesca Ferrer, Marie Antoinette Frick, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas
Funding agency: Instituto de Salud Carlos III
Funding: 247500
Reference: RD16/0025/0007
Duration: 01/01/2017 - 30/06/2022

Related news

The new protocol has the same efficacy as the standard one, but only a quarter of the duration, reducing dropout rates and side effects.

The initiative, carried out at the Consulate of Bolivia, has resulted in 307 new tests for the diagnosis of Chagas disease

The study shows that blocking the KLRG1 receptor helps to recover the activity of the natural killer cells of the immune system and reactivate the virus reservoir to fight infection.

Related professionals

Alba Torija Recasens

Alba Torija Recasens

Predoctoral researcher
Nephrology and kidney transplantation
Read more
Carmina Castellano Tejedor

Carmina Castellano Tejedor

Senior researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more
Concepció Jacobs Cachá

Concepció Jacobs Cachá

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Xavier Serra Ruiz

Xavier Serra Ruiz

Research technician
Physiology and Pathophysiology of the Digestive Tract
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.